Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 | P25021 | 5/20 | 0.36 |
| ▸ | DRD2 | P14416 | 4/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19980666 | 0.88 | DRD2 (0.35) | HRH2DRD2HTR2CHRH1SLC6A4 | |
| SCHEMBL19980607 | 0.80 | HRH2 (0.40) | HRH2 | |
| SCHEMBL19972458 | 0.79 | ROCK2 (0.35) | HRH2DRD2HTR2CHRH1SLC6A4 | |
| SCHEMBL21084722 | 0.79 | DRD2 (0.35) | HRH2DRD2HTR2CHRH1SLC6A4 | |
| SCHEMBL30524119 | 0.79 | ROCK2 (0.35) | HRH2DRD2HTR2CHRH1SLC6A4 | |
| SCHEMBL25135023 | 0.78 | DRD2 (0.34) | HRH2DRD2HTR2CHRH1SLC6A4 | |
| SCHEMBL19972570 | 0.76 | DRD2 (0.33) | HRH2DRD2HTR2CHRH1SLC6A4 | |
| SCHEMBL19972545 | 0.76 | HRH2 (0.41) | HRH2DRD2HTR2CROCK2 | |
| SCHEMBL31001189 | 0.76 | HRH2 (0.40) | HRH2DRD2HTR2CHRH1ROCK2 | |
| SCHEMBL19972548 | 0.76 | HRH2 (0.40) | HRH2DRD2HTR2CHRH1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4230627-A2 | INHIBITORS OF THE MENIN-MLL INTERACTION | Vitae Pharmaceuticals, LLC (US) | 2023-08-23 | — | — | EP | disclosed |